These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17585187)

  • 41. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection.
    Moreno S; García-Samaniego J; Moreno A; Ortega E; Pineda JA; del Romero J; Tural C; von Wichmann MA; Berenguer J; Castro A; Espacio R
    J Viral Hepat; 2009 Apr; 16(4):249-58. PubMed ID: 19215579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.
    Gonzalez SA; Fiel MI; Sauk J; Canchis PW; Liu RC; Chiriboga L; Yee HT; Jacobson IM; Talal AH
    J Viral Hepat; 2009 Feb; 16(2):141-8. PubMed ID: 19175868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
    Kim BK; Kim SA; Park YN; Cheong JY; Kim HS; Park JY; Cho SW; Han KH; Chon CY; Moon YM; Ahn SH
    Liver Int; 2007 Sep; 27(7):969-76. PubMed ID: 17696936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Grading and staging systems for inflammation and fibrosis in chronic liver diseases.
    Goodman ZD
    J Hepatol; 2007 Oct; 47(4):598-607. PubMed ID: 17692984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A clinical and histopathologic perspective on evolving noninvasive and invasive alternatives for liver biopsy.
    Van Leeuwen DJ; Balabaud C; Crawford JM; Bioulac-Sage P; Dhillon AP
    Clin Gastroenterol Hepatol; 2008 May; 6(5):491-6. PubMed ID: 18455694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group.
    McHutchison J; Poynard T; Afdhal N;
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1214-1220. PubMed ID: 16979947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver fibrosis and chronic viral hepatitis.
    Gutierrez-Reyes G; Gutierrez-Ruiz MC; Kershenobich D
    Arch Med Res; 2007 Aug; 38(6):644-51. PubMed ID: 17613356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Transient elastography for diagnosing liver fibrosis].
    Mössner BK; Pedersen C; Christensen PB
    Ugeskr Laeger; 2008 Aug; 170(33):2453-6. PubMed ID: 18761829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.
    Nahon P; Kettaneh A; Tengher-Barna I; Ziol M; de Lédinghen V; Douvin C; Marcellin P; Ganne-Carrié N; Trinchet JC; Beaugrand M
    J Hepatol; 2008 Dec; 49(6):1062-8. PubMed ID: 18930329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation.
    Rigamonti C; Donato MF; Fraquelli M; Agnelli F; Ronchi G; Casazza G; Rossi G; Colombo M
    Gut; 2008 Jun; 57(6):821-7. PubMed ID: 18218676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography.
    Rockey DC
    Gastroenterology; 2008 Jan; 134(1):8-14. PubMed ID: 18166342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
    Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
    Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relationship between liver disease stage and liver fibrosis: a tangled web.
    Germani G; Burroughs AK; Dhillon AP
    Histopathology; 2010 Dec; 57(6):773-84. PubMed ID: 20812954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Quantitative study of hepatic fibrosis in Hodgkin's disease (author's transl)].
    Mignot J; Bergue A; Baviera E; Malod-Panisset A
    Pathol Biol (Paris); 1979 Apr; 27(4):229-32. PubMed ID: 379762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninvasive Markers to Assess Liver Fibrosis.
    Czul F; Bhamidimarri KR
    J Clin Gastroenterol; 2016 Jul; 50(6):445-57. PubMed ID: 27105176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can serum markers be used to reliably detect liver fibrosis?
    Afdhal N
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):132-3. PubMed ID: 16265151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.